A Randomized Parallel Controlled Phase II Trial of Recombinant Human Endostatin Added to Neoadjuvant Chemotherapy for Stage III Breast Cancer
- Resource Type
- Article
- Source
- In
Clinical Breast Cancer August 2020 20(4):291-299 - Subject
- Language
- ISSN
- 1526-8209